低风险的MDS可以通过低甲基化剂治疗获得高回报吗?
1Moores Cancer Center at UC San Diego Health, La Jolla, CA.
NEJM evidence
|February 6, 2024
概括
骨髓质疏松症候群 (MDS) 的治疗取决于风险. 较高风险的MDS使用诸如阿扎西提丁之类的毒剂,而较低风险的MDS则专注于对贫血的支持性护理.
科学领域:
- 血液学 血液学 血液学
- 在瘤学瘤学.
背景情况:
- 骨髓质疏松症候群 (MDS) 的治疗是按风险分层的.
- 高风险的MDS患者接受有毒治疗.
- 较低风险的MDS患者接受支持性护理.
相关概念视频
Phase II Reactions: Methylation Reactions
191
Methylation is a phase II biotransformation process involving the attachment of a methyl group to a substrate. Enzymes known as methyltransferases orchestrate this reaction.
The mechanism of methylation unfolds in two stages. The first stage sees a methyltransferase enzyme facilitating the transfer of a methyl group from S-adenosylmethionine (SAM) to the substrate, forming S-adenosylhomocysteine (SAH). The second stage involves further metabolism of SAH into homocysteine, which can be recycled...
The mechanism of methylation unfolds in two stages. The first stage sees a methyltransferase enzyme facilitating the transfer of a methyl group from S-adenosylmethionine (SAM) to the substrate, forming S-adenosylhomocysteine (SAH). The second stage involves further metabolism of SAH into homocysteine, which can be recycled...
191
Abnormal Proliferation
4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K


